Sulfhydryl treatment of serum or plasma for the reduction of IgM antibodies
16 oct 2019
Acerca de este artículo
Publicado en línea: 16 oct 2019
Páginas: 135 - 139
DOI: https://doi.org/10.21307/immunohematology-2018-021
Palabras clave
© 2018 L.N. Blagg, published by Sciendo
Dithiothreitol (DTT) and 2-mercaptoethanol (2-ME) are sulfhydryl compounds that can be used to treat serum or plasma to denature IgM antibody reactivity. By using sulfhydryl agents, IgG and IgM antibodies can be separated, the relative amount of IgM and IgG antibodies can be determined, and the risk of hemolytic disease of the fetus and newborn can be assessed.